Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback